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Ly6D- common lymphoid progenitor
Osteocalcin+ cells
Bone marrowT cells are known to develop in the thymus. However, molecular events that control the transition from hemato-
poietic progenitor cells in the bone marrow to T precursor cells seeded in the thymus remained poorly deﬁned.
Our recent report showed that osteocalcin (Ocn)-expressing bone cells in the bone marrow have major impact
on T cell immunity by regulating T progenitor development in the bone marrow (Yu et al., 2015) [1]. Selective
endogenous depletion of Ocn+ cells by inducible diphtheria toxin receptor expression (OcnCre;iDTR) led to re-
duction of T-competent common lymphoid progenitors (Ly6D− CLPs) in the bone marrow and loss of T cells in
the thymus. Expression of the Notch ligand DLL4 by Ocn+ cells in the bone marrow ensures the production of
Ly6D− CLPs, and expression of chemotactic molecules CCR7 and PSGL1 to enable subsequent thymic seeding.
These data indicate that speciﬁc mesenchymal cells in bone marrow provide key molecular drivers enforcing
thymus-seeding progenitor generation and thereby directly link skeletal biology to the production of T cell
based adaptive immunity. Herewe present the transcriptome proﬁles of Ly6D− CLPs derived fromOcn+ cells de-
leted mice (OcnCre+;iDTR) compared to those derived from control littermates (OcnCre−;iDTR). These data are
publically available from NCBI Gene Expression Omnibus (GEO) with the accession number GSE66102.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).SpeciﬁcationsOrganism/cell line/tissue Mus musculus
Sex Females
Sequencer or array type Affymetrix Mouse430A microarray chip
Data format Raw data normalized
Experimental factors Ly6D− CLPs derived from osteocalcin + cells
depleted mice versus wildtype littermates.
Experimental features 20,000–30,000 Ly6D− CLPs derived from either
osteocalcin + cells depleted mice (OcnCre+;iDTR
mutant) or control littermates (OcnCre−;iDTR)
were isolated from the bone marrow by ﬂow
cytometry and subjected to microarray comparison
of global gene expression. Mice were 6–8 weeks
old. Three replicates were used for each
experimental condition.Consent Allowed to reuse citing original author.
Sample source location NA1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66102.. This is an open access article under2. Experimental design, materials and methods
2.1. Mouse models
To speciﬁcally delete mature osteolineage cells, the OC-cre strain
(from Dr. Thomas L. Clemens, Johns Hopkins University, MD, USA) [2],
which expressed Cre under the Osteocalcin promoter was crossed to
the iDTR strain [3]. Temporally controlled cell ablation was achieved
upon injection of diphtheria toxin into the OcnCre+/−;iDTR strain [1].
To study the effect of Ocn+ cells on hematopoiesis, OcnCre+/− injected
with diphtheria toxin or OcnCre+/−;iDTR injected with PBS served as
controls while OcnCre+/−;iDTR injected with diphtheria toxin were
used as mutants. For most experiments, 25 ng diphtheria toxin in PBS/g
of body weight was injected daily into both control and mutant animals
for 28 days from 4 weeks of age to achieve an acute deletion of speciﬁc
osteolineage populations. Mice were harvested for analysis the next day
after the last dose of diphtheria injection. For all experiments, littermates
were used as controls. All animal usage and procedures performed
were approved by the Institutional Animal Care and Use Committee
of Massachusetts General Hospital.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Heat map illustration of 30 differential genes among the 400 genes identiﬁedwhen
comparing the transcriptome of T competent progenitors (Ly6D− CLPs) isolated from
Ocn+ deleted mice compared to control littermates. Red represents overexpression
whereas blue means lower expression.
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Before sacriﬁce, peripheral blood was collected from each mouse
and subjected to complete blood cell count. For each mouse, tibiae, fe-
murs, iliac crests, spines, ulnae, radii, and humeri were collected for
bone marrow cells. In addition, spleen and thymus were also collected
for lymphocyte staining. Changes in hematopoietic populations were
quantiﬁed by ﬂow cytometry. Bone marrow cells harvested from each
animal were counted. We routinely stain 5 × 107 cells per sample for
the hematopoietic stem population, and 1 × 107 cells per sample for
each progenitor and mature population. Lineage cocktail consists of
biotinylated B220, CD3e, CD4, CD8a, CD19, CD11b, Gr1, Ter119, CD11c,
and NK1.1 antibodies. Fluorescence conjugated to streptavidin was
used to recognize lineage cocktail. The following antibody combinations
were used to recognize Ly6D− CLP (Lineage-Paciﬁc Orange, Sca-Paciﬁc
Blue, cKit-APC-Cy7, CD127-PE-Cy7, Thy1.2-FITC, Ly6D-APC).
4. Microarrays
Ly6D− CLPswere sorted from6 to 8weeks old OcnCre;iDTRmutants
and controls using the FACSAria following daily DT treatment for
4 weeks. RNA was extracted using the TRIzol® (Invitrogen) according
to the manufacturer's instructions. Samples were processed by the
NuGen Ovation V2 laboratory Process in the microarray core facility of
Dana-Farber Cancer Institute. Brieﬂy, ﬁrst stand cDNA was prepared
from total RNA using a DNA/RNA chimeric primer and a reverse tran-
scriptase. The resulting double stranded cDNAwith a unique heterodu-
plex at the 5' end of the antisense strand were ampliﬁed using SPIATM
ampliﬁcation, a repeated process of SPIATM DNA/RNA primer hybridi-
zation, DNA replication, strand displacement and RNA cleavage which
resulted in a rapid accumulation of cDNAwith sequence complementa-
ry to the original RNA. The SPIATM ampliﬁed cDNA was puriﬁed using
the Zymo Research DNA Clean & Concentrator™ system. The puriﬁed
cDNA was fragmented through a chemical and enzymatic process and
labeled via enzymatic attachment of a biotin-labeled nucleotide to the
3′-hydroxyl end of the fragmented cDNA. The biotinylated cDNA was
added to a hybridization solution containing several biotinylated
control oligonucleotides (for quality control), and hybridized to the
Mouse430A microarray chip overnight at 45 °C. The chips were
then transferred to a ﬂuidics instrument that performs washes to
remove cDNA that has not hybridized to its complementary oligonu-
cleotide probe. The bound cDNA was then ﬂuorescently labeled
using phycoerythrin-conjugated streptavidin (SAPE); additional
ﬂuors were then added using biotinylated anti-streptavidin antibody
and additional SAPE. Each cDNA bound at its complementary oligo-
nucleotide was excited using a confocal laser scanner, and the posi-
tions and intensities of the ﬂuorescent emissions were captured.
These measures provide the basis of subsequent biostatistical analysis.
5. Quality assessment
Standard QA/QC analyses involved chip analysis with the
assayQualityMetrics BioConductor package and found no signiﬁcant
quality issues with any of the chips, as determined by (among other
methods) visual inspection, intensity distributions or RNA degradation
plots. The data was background corrected and normalized with RMA
(Robust Multichip Average) using the “affy” BioConductor package.
Values in the data matrix represent log2 normalized intensity values.
6. Differential expression quantiﬁcation and classiﬁcation
The selected database comprises 6 expression measurements of
41,345 genes, 3 in the ﬁrst condition and 3 in the second. The recorded
expression values ranged between 4.023 and 10,198.29. Supervised
learning or class predictionmethods were used for molecular classiﬁca-
tion and pattern recognition. This analysis involves selecting thefeatures (genes) most correlated with a phenotypic distinction of inter-
est. These features or “marker genes” are biologically interesting in
themselves but they can also be used as the input of a classiﬁcation al-
gorithm that uses existing “labeled” samples to build a model to predict
the labels for future samples. Genes correlated with a binary class dis-
tinction, for example a morphological or clinical phenotype, is directly
identiﬁed and selected by using a “distance” metric, for example t-test
statistic = (mA − mB) ÷ (s2A + s2B) [m and s are the means and
std. dev. per class] or Signal to noise ratio = (mA− mB) / (sA + sB)
[m and s are the means and std. dev. per class]. Our analysis generated
Table 1
List of 30 genes overexpressed in mutant Ly6D- CLPs compared to control Ly6D- CLPs.
Accession T-test P value FDR Fold change Description
17523486 26.2253 0 0.8156 1.1068 Zfp105
17208361 19.9693 0.0001 0.8156 1.2735 –
17399895 15.5519 0.0025 0.8156 1.113 Sprr2k
17264448 13.6163 0.0032 0.8156 1.1092 Arhgef15
17512177 13.5854 0.0028 0.8156 1.4664 ENSMUST00000153288
17391347 13.4535 0.0002 0.8156 1.2012 Nphp1
17494714 12.2023 0.0005 0.8156 1.208 Olfr710
17544210 12.0084 0.0015 0.8156 1.1814 ENSMUST00000158796
17347443 11.084 0.002 0.8156 1.2347 Gm10494
17533124 10.7079 0.0006 0.8156 1.2265 Ssxb9
17305243 9.913 0.0097 0.8156 1.2408 Sftpd
17254041 9.4857 0.0008 0.8156 1.5203 Ccl2
17259689 9.2744 0.0077 0.8156 1.301 AK079017
17307801 9.0039 0.0012 0.8156 1.2928 Gulo
17430674 8.9262 0.0024 0.8156 1.4329 ENSMUST00000152128
17312223 8.9021 0.0009 0.8156 1.307 BC025446
17548581 8.7592 0.0016 0.8156 1.2293 Gm3257
17219374 8.6936 0.001 0.8156 1.2858 Alyref2
17302289 8.456 0.0048 0.8156 1.1399 Pcdh17
17466729 8.4263 0.0056 0.8156 1.2631 4921507P07Rik
17475498 8.3725 0.0085 0.8156 1.1133 Cyp2f2
17529871 8.0847 0.0026 0.8156 1.1418 Acpl2
17432985 8.0258 0.0022 0.8156 1.3174 ENSMUST00000138492
17467548 7.9069 0.01 0.8156 1.0905 Igkv6-14
17232499 7.8339 0.002 0.8156 1.2085 Rsph4a
17550502 7.6586 0.0035 0.8156 1.1793 17.94637
17286115 7.6359 0.0087 0.8156 1.3329 Prl3d1
17423885 7.5189 0.0032 0.8156 1.2563 Gm136
17433901 7.5064 0.0151 0.8156 1.1834 Tas1r3
17407496 7.2659 0.011 0.8156 1.2624 Crct1
102 V.W.C. Yu, D.T. Scadden / Genomics Data 5 (2015) 100–102400 selected differential genes. Fig. 1 is a color map illustrating 30 genes
overexpressed in mutant Ly6D− CLPs compared to control Ly6D− CLPs.
Table 1 shows the mean, standard deviation, score, and fold change of
the 30 genes.
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